Structural Formula (Rop02 0004 01)
Ropivacaine Hydrochloride Injection, Solution
Product Images NDC 25021-652
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ropivacaine Hydrochloride (NDC 25021-652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Rop02 0007 02
The description is "Ropivacaine HCI Injection, USP 100 mL Bag!".*
Rop02 0007 03
This text describes a medication with the NDC number 25021-652-82, containing Ropivacaine HCI at a concentration of 5 mg per mL in a 100 mL bag. It is intended for infiltration, nerve block, and epidural administration only, and is not for intravenous administration. The medication is single-use only, and any unused portion should be discarded. Each mL contains ropivacaine HCI, sodium chloride, and water for injection, with a pH of approximately 4.0 to 6.0. Usual dosage instructions are located in the package insert. The medication should not be used if the solution is discolored or contains a precipitate. It is designed to be stored at 20° to 25°C (68° to 77°F). The medication is sterile, nonpyrogenic, preservative-free, PVC-free, and DEHP-free. The container and container closure are not made with natural rubber latex. The medication was manufactured for SAGENT Pharmaceuticals in Schaumburg, IL, and made in Switzerland. There is a LOT number and EXP date provided, but they cannot be read in the text given.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
